Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder

Research output: Contribution to journalJournal articleResearchpeer-review

  1. No evidence for the effectiveness of IV ketamine for treatment resistant mood disorders in retrospective study

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations
The α7 nicotinic acetylcholine receptor (nAChR) is involved in cognitive function and synaptic plasticity. Consequently, changes in α7 nAChR function have been implicated in a variety of mental disorders, especially schizophrenia. However, there is little knowledge regarding the levels of the α7 nAChR in patients with bipolar disorder.
Original languageEnglish
JournalBipolar Disorders
Issue number7-8
Pages (from-to)701-7
Number of pages7
Publication statusPublished - 2011

ID: 33247861